Maximize your thought leadership

FAQ: American Heart Association's 2025 Health Tech Competition Finalists

TL;DR

The American Heart Association's Health Tech Competition offers innovators access to the Innovators' Network, providing competitive advantages in clinical study development and market validation.

Five health tech companies will present AI and medical innovations at Scientific Sessions 2025, evaluated by expert judges on validity, scientific rigor, and patient impact.

These cardiovascular and stroke innovations from Brainomix, Cambrian Health, and others aim to reduce global mortality rates and improve patient outcomes worldwide.

Berlin's Noah Labs transforms voice into a digital biomarker while PolyVascular develops minimally invasive solutions for children with congenital heart disease.

Found this article helpful?

Share it with your network and spread the knowledge!

FAQ: American Heart Association's 2025 Health Tech Competition Finalists

The competition provides a live forum for healthcare technology companies to present innovations designed to prevent or treat cardiovascular conditions, including high blood pressure, stroke, heart failure and related conditions, helping bridge the gap between healthcare innovation and adoption.

It addresses the critical gap between healthcare innovation and adoption for heart disease and stroke, which are the world's leading causes of death, by showcasing technologies that can improve patient outcomes and advance cardiovascular care.

The finalists include: Brainomix (AI-powered stroke diagnosis software), Cambrian Health (AI platform for clinical best practices), Lumia (wearables for orthostatic intolerance), Noah Labs (voice-based digital biomarkers for cardiometabolic diseases), and PolyVascular (minimally invasive solutions for congenital heart disease in children).

Final presentations will be delivered live at the New Orleans Ernest N. Morial Convention Center on November 8-9, 2025, from 11:30 a.m. to 1 p.m. CT during the Health Innovation Pavilion at Scientific Sessions 2025.

Presentations will be judged based on three criteria: Validity (how well the prototype functions with customers), Scientific Rigor (use of evidence-based health research), and Impact (extent of patient outcome improvement through innovative technology).

The expert panel includes medical professionals, venture capitalists, and healthcare leaders such as Dr. Eric D. Peterson, Lee Shapiro, Lisa Suennen, Ken Nelson, Craig Beam, Tim Benner, Henry Peck, Star Jones, Dr. Lee H. Schwamm, and Dr. Joseph C. Wu.

The innovations target cardiovascular conditions including stroke, high blood pressure, heart failure, orthostatic intolerance, chronic blood flow disorders, cardiometabolic diseases, and congenital heart disease in children.

By showcasing validated technologies that improve patient outcomes, the competition helps accelerate the adoption of innovative solutions that can enhance diagnosis, treatment, and management of cardiovascular diseases in clinical practice.

Curated from NewMediaWire

blockchain registration record for this content
NewsRamp Editorial Team

NewsRamp Editorial Team

@newsramp

NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.